Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 05-Mar-24 6:00 PM View:  | Ryan Barbara Director | Mink Therapeutics, Inc. (INKT) | 01-Mar-24 | Grant | 18,685 | $0.95 | $17,750.80 | 28% 67.93K to 86.62K | |
| 05-Mar-24 6:00 PM View: | Behner Peter Director | Mink Therapeutics, Inc. (INKT) | 01-Mar-24 | Grant | 16,185 | $0.95 | $15,375.80 | 28% 58.84K to 75.03K | |
| 05-Mar-24 6:00 PM View: | Corvese Brian Director | Mink Therapeutics, Inc. (INKT) | 01-Mar-24 | Grant | 18,816 | $0.95 | $17,875.20 | 5% 346.71K to 365.53K | |
| 05-Mar-24 6:00 PM View: | Wiinberg Ulf Director | Mink Therapeutics, Inc. (INKT) | 01-Mar-24 | Grant | 15,790 | $0.95 | $15,000.50 | 4% 352.84K to 368.63K | |
| 05-Dec-23 6:05 PM View: | Behner Peter Director | Mink Therapeutics, Inc. (INKT) | 01-Dec-23 | Grant | 14,784 | $1.04 | $15,375.40 | 34% 44.06K to 58.84K | |
| 05-Dec-23 6:05 PM View: | Corvese Brian Director | Mink Therapeutics, Inc. (INKT) | 01-Dec-23 | Grant | 17,188 | $1.04 | $17,875.50 | 5% 329.52K to 346.71K | |
| 05-Dec-23 6:05 PM View: | Wiinberg Ulf Director | Mink Therapeutics, Inc. (INKT) | 01-Dec-23 | Grant | 14,424 | $1.04 | $15,001.00 | 4% 338.42K to 352.84K | |
| 05-Dec-23 6:11 PM View: | Ryan Barbara Director | Mink Therapeutics, Inc. (INKT) | 01-Dec-23 | Grant | 17,068 | $1.04 | $17,750.70 | 34% 50.86K to 67.93K | |
| 16-Oct-23 5:49 PM View: | Agenus Inc 10% Owner | Mink Therapeutics, Inc. (INKT) | 16-Oct-23 | Purchase | 429 | $1.10 | $471.56 | < 1% 21.77M to 21.77M | |
| 16-Oct-23 5:49 PM View: | Agenus Inc 10% Owner | Mink Therapeutics, Inc. (INKT) | 13-Oct-23 | Purchase | 19,373 | $1.10 | $21,310.30 | < 1% 21.75M to 21.77M | |
| 16-Oct-23 5:49 PM View: | Agenus Inc 10% Owner | Mink Therapeutics, Inc. (INKT) | 12-Oct-23 | Private Purchase | 3,173 | $1.10 | $3,488.40 | < 1% 21.75M to 21.75M | |
| 13-Oct-23 8:18 PM View: | Buell Jennifer Chief Executive Officer Director | Mink Therapeutics, Inc. (INKT) | 11-Oct-23 | Disposition (other) | 695,750 | -- | -- | (75%) 927.91K to 232.16K | |
| 06-Oct-23 4:26 PM View: | Agenus Inc 10% Owner | Mink Therapeutics, Inc. (INKT) | 04-Oct-23 | Private Purchase | 15,001 | $1.09 | $16,379.60 | < 1% 21.73M to 21.75M | |
| 03-Oct-23 10:00 PM View: | Buell Jennifer Chief Executive Officer Director | Mink Therapeutics, Inc. (INKT) | 03-Oct-23 | Payment of Exercise | 65,000 | $0.94 | $61,418.50 | (7%) 992.91K to 927.91K | |
| 03-Oct-23 10:00 PM View: | Buell Jennifer Chief Executive Officer Director | Mink Therapeutics, Inc. (INKT) | 02-Oct-23 | Payment of Exercise | 58,550 | $1.04 | $61,155.50 | (6%) 1.05M to 992.91K | |
| 03-Oct-23 10:00 PM View: | Buell Jennifer Chief Executive Officer Director | Mink Therapeutics, Inc. (INKT) | 29-Sep-23 | Payment of Exercise | 25,000 | $1.15 | $28,845.00 | (2%) 1.08M to 1.05M | |
| 29-Sep-23 4:30 PM View: | Buell Jennifer Chief Executive Officer | Mink Therapeutics, Inc. (INKT) | 27-Sep-23 | Option Exercise | 695,750 | -- | -- | 183% 380.71K to 1.08M | |
| 06-Sep-23 5:02 PM View: | Corvese Brian Director | Mink Therapeutics, Inc. (INKT) | 01-Sep-23 | Grant | 12,244 | $1.46 | $17,876.20 | 4% 317.28K to 329.52K | |
| 06-Sep-23 5:00 PM View: | Wiinberg Ulf Director | Mink Therapeutics, Inc. (INKT) | 01-Sep-23 | Grant | 9,590 | $1.46 | $14,001.40 | 7% 128.83K to 138.42K | |
| 06-Sep-23 5:01 PM View: | Ryan Barbara Director | Mink Therapeutics, Inc. (INKT) | 01-Sep-23 | Grant | 12,158 | $1.46 | $17,750.70 | 31% 38.71K to 50.86K | |
| 06-Sep-23 5:04 PM View: | Behner Peter Director | Mink Therapeutics, Inc. (INKT) | 01-Sep-23 | Grant | 10,531 | $1.46 | $15,375.30 | 31% 33.53K to 44.06K | |
| 06-Sep-23 5:01 PM View: | Baldoni John Director | Mink Therapeutics, Inc. (INKT) | 01-Sep-23 | Grant | 9,846 | $1.46 | $14,375.20 | 31% 31.35K to 41.19K | |
| 31-Aug-23 5:53 PM View: | Agenus Inc 10% Owner | Mink Therapeutics, Inc. (INKT) | 29-Aug-23 | Private Purchase | 29,678 | $1.52 | $45,015.60 | < 1% 21.71M to 21.73M | |
| 28-Aug-23 5:15 PM View: | Agenus Inc 10% Owner | Mink Therapeutics, Inc. (INKT) | 28-Aug-23 | Purchase | 12,808 | $1.45 | $18,570.30 | < 1% 21.69M to 21.71M | |
| 28-Aug-23 5:15 PM View: | Agenus Inc 10% Owner | Mink Therapeutics, Inc. (INKT) | 24-Aug-23 | Private Purchase | 170,244 | $1.54 | $262,908.00 | < 1% 21.52M to 21.69M | |
| 02-Jun-23 7:42 PM View: | Ryan Barbara Director | Mink Therapeutics, Inc. (INKT) | 01-Jun-23 | Grant | 10,086 | $1.76 | $17,751.40 | 35% 28.84K to 38.93K | |
| 02-Jun-23 7:41 PM View: | Behner Peter Director | Mink Therapeutics, Inc. (INKT) | 01-Jun-23 | Grant | 8,736 | $1.76 | $15,375.40 | 35% 24.98K to 33.72K | |
| 02-Jun-23 7:39 PM View: | Baldoni John Director | Mink Therapeutics, Inc. (INKT) | 01-Jun-23 | Grant | 8,168 | $1.76 | $14,375.70 | 35% 23.36K to 31.53K | |
| 02-Jun-23 7:43 PM View: | Corvese Brian Director | Mink Therapeutics, Inc. (INKT) | 01-Jun-23 | Grant | 10,157 | $1.76 | $17,876.30 | 3% 307.35K to 317.5K | |
| 02-Jun-23 7:40 PM View: | Wiinberg Ulf Director | Mink Therapeutics, Inc. (INKT) | 01-Jun-23 | Grant | 7,955 | $1.76 | $14,000.80 | 2% 321.05K to 329.01K | |
| 12-May-23 5:18 PM View: | Agenus Inc 10% Owner | Mink Therapeutics, Inc. (INKT) | 11-May-23 | Purchase | 23,361 | $1.43 | $33,347.80 | < 1% 21.62M to 21.64M | |
| 12-May-23 5:18 PM View: | Agenus Inc 10% Owner | Mink Therapeutics, Inc. (INKT) | 10-May-23 | Private Purchase | 22,065 | $1.51 | $33,296.10 | < 1% 21.6M to 21.62M | |
| 05-May-23 6:27 PM View: | Armen Garo H Director | Mink Therapeutics, Inc. (INKT) | 05-May-23 | Sale | 100,000 | $0.95 | $94,850.00 | (5%) 1.97M to 1.87M | |
| 05-May-23 6:00 PM View: | Agenus Inc 10% Owner | Mink Therapeutics, Inc. (INKT) | 05-May-23 | Purchase | 100,200 | $0.95 | $95,100.00 | < 1% 21.49M to 21.59M | |
| 05-May-23 6:00 PM View: | Agenus Inc 10% Owner | Mink Therapeutics, Inc. (INKT) | 04-May-23 | Purchase | 21,473 | $1.22 | $26,246.40 | < 1% 21.47M to 21.49M | |
| 05-May-23 6:00 PM View: | Agenus Inc 10% Owner | Mink Therapeutics, Inc. (INKT) | 03-May-23 | Private Purchase | 128,689 | $1.08 | $138,843.00 | < 1% 21.34M to 21.47M | |
| 03-May-23 5:39 PM View: | Agenus Inc 10% Owner | Mink Therapeutics, Inc. (INKT) | 01-May-23 | Disposition (other) | 4,988,270 | -- | -- | (19%) 26.33M to 21.34M | |
| 03-Mar-23 2:54 PM View: | Behner Peter Director | Mink Therapeutics, Inc. (INKT) | 01-Mar-23 | Grant | 7,357 | $2.09 | $15,376.10 | 42% 17.63K to 24.98K | |
| 03-Mar-23 3:00 PM View: | Baldoni John Director | Mink Therapeutics, Inc. (INKT) | 01-Mar-23 | Grant | 6,878 | $2.09 | $14,375.00 | 42% 16.48K to 23.36K | |
| 03-Mar-23 3:15 PM View: | Corvese Brian Director | Mink Therapeutics, Inc. (INKT) | 01-Mar-23 | Grant | 8,553 | $2.09 | $17,875.80 | 3% 298.8K to 307.35K | |
| 03-Mar-23 3:23 PM View: | Wiinberg Ulf Director | Mink Therapeutics, Inc. (INKT) | 01-Mar-23 | Grant | 6,699 | $2.09 | $14,000.90 | 2% 314.35K to 321.05K | |
| 03-Mar-23 2:58 PM View: | Ryan Barbara Director | Mink Therapeutics, Inc. (INKT) | 01-Mar-23 | Grant | 8,493 | $2.09 | $17,750.40 | 42% 20.35K to 28.84K | |
| 11-Jan-23 4:58 PM View: | Buell Jennifer Chief Executive Officer | Mink Therapeutics, Inc. (INKT) | 09-Jan-23 | Grant | 171,990 | $2.32 | $399,017.00 | 82% 208.72K to 380.71K | |
| 12-Jan-23 10:48 AM View: | van Dijk Marcus Antonius Chief Scientific Officer | Mink Therapeutics, Inc. (INKT) | 09-Jan-23 | Payment of Exercise | 24,265 | $2.32 | $56,294.80 | (47%) 51.63K to 27.36K | |
| 12-Jan-23 10:48 AM View: | van Dijk Marcus Antonius Chief Scientific Officer | Mink Therapeutics, Inc. (INKT) | 09-Jan-23 | Grant | 51,628 | $2.32 | $119,777.00 | 100% 0 to 51.63K | |
| 05-Dec-22 6:27 PM View: | Wiinberg Ulf Director | Mink Therapeutics, Inc. (INKT) | 01-Dec-22 | Grant | 5,364 | $2.61 | $14,000.00 | 2% 308.99K to 314.35K | |
| 05-Dec-22 5:18 PM View: | Ryan Barbara Director | Mink Therapeutics, Inc. (INKT) | 01-Dec-22 | Grant | 6,801 | $2.61 | $17,750.60 | 50% 13.55K to 20.35K | |
| 05-Dec-22 5:10 PM View: | Behner Peter Director | Mink Therapeutics, Inc. (INKT) | 01-Dec-22 | Grant | 5,891 | $2.61 | $15,375.50 | 50% 11.74K to 17.63K | |
| 05-Dec-22 5:22 PM View: | Baldoni John Director | Mink Therapeutics, Inc. (INKT) | 01-Dec-22 | Grant | 5,508 | $2.61 | $14,375.90 | 50% 10.97K to 16.48K | |
| 05-Dec-22 5:20 PM View: | Corvese Brian Director | Mink Therapeutics, Inc. (INKT) | 01-Dec-22 | Grant | 6,849 | $2.61 | $17,875.90 | 2% 291.95K to 298.8K |
